Clinical Trials Logo

Prolapse clinical trials

View clinical trials related to Prolapse.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT04444830 Withdrawn - Surgery Clinical Trials

Sprix for Postoperative Pain Control Following Gynecologic Surgery

Start date: January 2021
Phase: Phase 4
Study type: Interventional

The ongoing opioid epidemic has altered both how physicians prescribe narcotics and patients' perceptions of those prescriptions. Along with increased scrutiny regarding the quantity of opioids that be may prescribed after acute injury, for chronic conditions and following surgery the healthcare industry as a whole continues to search for alternative medications that provide adequate pain relief and have a reduced tendency for abuse/dependence/addition. To that end this study has the following aims: 1. To evaluate the amount of opioids consumed following minimally invasive, female pelvic surgery when patients' postoperative pain is managed via: 1. Acetaminophen plus Ibuprofen plus breakthrough pain opioids (Standard protocol) 2. Acetaminophen plus Intranasal Ketorolac Tromethamine plus opioids for breakthrough pain (Sprix protocol) 2. Patient satisfaction with the aforementioned methods 3. Evaluate and compare pain scores via validated questionnaire Hypothesis: Primary: 1. Patients prescribed intranasal Ketorolac (Sprix protocol) will consume significantly less Morphine Milliequivalents (mEqs) of narcotics compared to the standard protocol following minimally invasive female pelvic surgery. Secondary: 1. Patients in the Sprix protocol will have lower Visual Analog Scale (VAS) measures of pain which will be measured on a 0-10 scale where 0 denotes no pain and 10 denotes maximum experience of pain 2. Patients in the Sprix protocol will have lower numeric pain score and on POD#4 3. Patients in the Sprix protocol will have higher Quality of Recovery 40 (QoR-40 )scores on POD#1 4. Patients in the Sprix protocol will have higher QoR-40 scores on POD#4 5. Patients will not have any significant difference in overall surgical satisfaction on POD#1 and POD#4 using a numerical satisfaction score 6. Patients in the Sprix protocol will be more likely to consume no narcotics at all once discharged to home

NCT ID: NCT04118777 Withdrawn - Endometriosis Clinical Trials

Postoperative Narcotic Use After Laparoscopic Gynecologic Surgery

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

This will be a prospective, randomized, double blinded placebo-controlled study at Erlanger hospital. Eligible patients who provide consent will be randomized into one of two arms receiving continuous intra-peritoneal local anesthetic with 0.2% Ropivacaine or saline.

NCT ID: NCT03094442 Withdrawn - Quality of Life Clinical Trials

Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?

Start date: December 2016
Phase: N/A
Study type: Interventional

The primary aim is to evaluate whether standard administration of Dexamethasone at the time of general anesthesia induction at the time of minimally invasive sacrocolpopexy (MISC) would result in improved quality of recovery (QoR).

NCT ID: NCT02829749 Withdrawn - Clinical trials for Cardiovascular Diseases

Effectiveness and Safety of Mitral Valve Repair With the NeoChord DS1000 Artificial Chordae Delivery System Versus Conventional Surgery in Patients With Severe Primary Mitral Regurgitation Due to Isolated Leaflet Prolapse

MITRACHORD
Start date: June 2020
Phase: N/A
Study type: Interventional

The main objective is to assess the effectiveness and safety of the NeoChord DS1000 repair technique as compared with conventional open-heart on-pump mitral valve surgery in patients with severe primary mitral regurgitation.

NCT ID: NCT02409498 Withdrawn - Clinical trials for Pelvic Organ Prolapse

Use of Pre-Emptive Pudendal Nerve Block for Pelvic Reconstructive Surgery

Start date: October 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effectiveness of perineal pain control via injection of a local anesthetic to numb the pudendal nerve. The medication which is commonly used for this block is called marcaine. This is called a pudendal block it has been used in obstetrical and gynecologic surgeries for several decades. The goal of this study is to reduce the amount of pain medications taken post operatively after pelvic reconstructive surgery. Subjects undergoing pelvic reconstructive surgery will be recruited during the pre-op visit. Subjects will be asked about their pain level in the PACU and also asked to document their pain score days 1 and 2 post op. They will also be asked to keep a medication log for 14 days post op.

NCT ID: NCT02060331 Withdrawn - Clinical trials for Pelvic Organ Prolapse

Severe Pelvic Organ Prolapse and Post-Obstructive Diuresis (SOPPO) Pilot Study

SOPPO
Start date: January 2014
Phase: N/A
Study type: Observational

In our experience, women with severe pelvic organ prolapse (POP) frequently have bothersome nocturia. The International Continence Society (ICS) defines nocturia as "having to wake at night one or more times to void." Though some of this nocturia may be secondary to obstructed bladder emptying, the investigators hypothesize that in some women compression of the bilateral ureters due to prolapsed pelvic organs during the day and subsequent relief of that prolapse while the patient lays supine overnight results in nighttime post-obstructive diuresis (inability to concentrate urine) and resultant large nighttime urine volumes and nocturia. Previous case reports have proposed that vaginal and uterine vault prolapse causes obstruction due to descent of the bladder floor which leads to compression of the bilateral ureters between the uterus and the borders of the genital opening. No large prospective studies, however, have evaluated the possible impact of this phenomenon on patients or the possible post-operative changes following surgical correction of POP. Using the Nocturnal Enuresis, and Sleep interruption Questionnaire (NNES-Q), voiding diaries, and urine studies, the investigators aim to evaluate the pre-operative and post-operative voiding habits and urinary parameters of women with severe pelvic organ prolapse and bothersome nocturia who undergo colpocleisis. Colpocleisis is a procedure which surgically obliterates the vaginal lumen to treat severe POP in properly counseled patients with >90% satisfaction rates. Other treatments offered to women, such as the laparoscopic or open sacrocolpopexy, uterosacral ligament suspension, and sacrospinous ligament suspension, also offer high rates of success. The investigators aim to determine whether surgical correction of severe pelvic organ prolapse, to be defined as either with colpocleisis, laparoscopic or open sacrocolpopexy, uterosacral ligament suspension, or sacrospinous ligament suspension, results in improvement and/or resolution of nocturia and post-obstructive diuresis.

NCT ID: NCT01530191 Withdrawn - Clinical trials for Pelvic Organ Prolapse

Factors Affecting Perioperative Outcomes

Start date: September 2011
Phase: N/A
Study type: Observational

The specific aim of this study is to determine if pre-existing depression and anxiety affect perioperative outcomes measures patients undergoing surgery for pelvic organ prolapse. - Hypothesis 1: Patients with depression will have increased analgesic use and longer hospital stays postoperatively - Hypothesis 2: Patients with anxiety will have increased analgesic use and longer hospital stays postoperatively. A secondary aim is to characterize the incidence and severity of depression and anxiety in patients scheduled to undergo surgery for pelvic organ prolapse.

NCT ID: NCT01525498 Withdrawn - Clinical trials for Pelvic Organ Prolapse

Foley Catheterization Following Sacrocolpopexy

Start date: August 2011
Phase: N/A
Study type: Observational

The objective of this study is to prospectively evaluate the effects of early versus delayed removal of transuretheral catheters following sacrocolpopexy. The investigators specific aim is to determine the optimal time of removal of an indwelling transurethral catheter postoperatively in an effort to reduce the risk of postoperative urinary retention and urinary tract infection associated with catheter use. The investigators hypotheses are as follows: Hypothesis 1: Longer duration of postoperative catheter use will result in decreased postoperative urinary retention. Hypothesis 2: Shorter duration of postoperative catheter use will result in lower incidence of urinary tract infection.

NCT ID: NCT01387685 Withdrawn - Clinical trials for Pelvic Floor Prolapse

Treatment of Pelvic Organ Prolapse by PIVS Versus Surgeon Cut Mesh

Start date: February 2009
Phase: N/A
Study type: Observational

Women with pelvic floor prolapse who underwent surgery with mesh will be enrolled. The investigators will compare data from the chart, telephone interviews and physical examinations between those who underwent mesh placement to those who underwent placement of PIVS.

NCT ID: NCT01383291 Withdrawn - Clinical trials for Pelvic Floor Prolapse

Prolift Versus IVS for Pelvic Floor Prolapse

Start date: February 2009
Phase: N/A
Study type: Observational

- Women who underwent mesh or sling procedures to correct pelvic organ prolapse will be enrolled. - Their data will be collected from the files. - Comparison between two groups will be carried our: Those who underwent a posterior IVS and those who underwent posterior prolift procedure. - The data will be obtained by questionaires by a telephone interview by a physician who did not participate in the surgery. - Follow-up physical examination data will also be obtained.